42 U.S.C. § 244c — Cardiomyopathy research

(a) In general. The Secretary, working with the Director of the National Institutes of Health, may expand and coordinate NIH's research on cardiomyopathy. This research may look at what causes cardiomyopathy, including genetic causes and molecular markers; the long-term health outcomes for people with cardiomyopathy, from infants to elderly people; and studies that use long-term data and past records to find effective treatments and outcomes. (b) Nonduplication. The Secretary must make sure this research doesn't needlessly repeat work already being done by other agencies or offices within the Department of Health and Human Services. (c) NIH report. Within 18 months after December 23, 2024, the Secretary — working with the NIH Director — must send Congress a report. The report must describe NIH's ongoing cardiomyopathy research, lay out a research agenda for adult forms of the disease, describe plans for researching cardiomyopathy in children, and identify where more research is needed most. (d) Cardiomyopathy defined. In this section, "cardiomyopathy" has the same meaning as in section 244a.